Identification of CT Values That Could Be Predictive of Necrosis (N-CTav) in Hepatocellular Carcinoma after Lenvatinib Treatment.

Makoto ChumaHideki YokooAtsushi HiraokaKazuhiko UedaTakahiro YokoyamaKunihiko TsujiNoritomo ShimadaHaruki UojimaSatoshi KobayashiNobuhiro HattoriTomomi OkuboMasanori AtsukawaToru IshikawaKoichi TakaguchiAkemi TsutsuiHidenori ToyodaToshifumi TadaYoshinori SaitoShunji HiroseTakaaki TanakaKazuhisa TakedaMasako OtaniZenjiro SekikawaTsunamasa WatanabeHisashi HidakaManabu MorimotoKazushi NumataTatehiro KagawaMichiie SakamotoTakashi KumadaShin Maeda

Published in: Current oncology (Toronto, Ont.) (2022)

The cut-off value of 30.2 HU for CTav (N30-CTav) might be appropriate for identifying post-lenvatinib necrosis in HCC, and an N30-CTav occupancy rate of >30.6% might be a predictor of maintenance of CR. Use of these indicators have the potential to impact systemic chemotherapy for HCC.

Keyphrases

computed tomography
image quality
magnetic resonance imaging
locally advanced
dual energy
contrast enhanced
magnetic resonance
positron emission tomography
radiation therapy
combination therapy
chemotherapy induced